pI: 8.3582 |
Length (AA): 233 |
MW (Da): 25865 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 205 | 1orn (A) | 5 | 208 | 43.00 | 0 | 1 | 1.49764 | -1.18 |
5 | 229 | 3g0q (A) | 10 | 245 | 25.00 | 0.0000000092 | 1 | 1.30777 | -0.37 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126913)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G05900 | endonuclease III 2 |
Arabidopsis thaliana | AT2G31450 | protein NTH1 |
Babesia bovis | BBOV_I003140 | base excision DNA repair protein, HhH-GPD family domain containing protein |
Brugia malayi | Bm1_27990 | Endonuclease III-like protein 1 |
Candida albicans | CaO19.12564 | similar to S. cerevisiae NTG1 (YAL015C) endonuclease III-like glycosylase involved in DNA repair |
Candida albicans | CaO19.5098 | similar to S. cerevisiae NTG1 (YAL015C) endonuclease III-like glycosylase involved in DNA repair |
Caenorhabditis elegans | CELE_R10E4.5 | Protein NTH-1, isoform C |
Cryptosporidium hominis | Chro.70202 | endonuclease III |
Cryptosporidium parvum | cgd7_1720 | endonuclease III, putative |
Chlamydia trachomatis | CT_697 | endonuclease III |
Dictyostelium discoideum | DDB_G0277247 | hypothetical protein |
Drosophila melanogaster | Dmel_CG9272 | CG9272 gene product from transcript CG9272-RA |
Escherichia coli | b1633 | DNA glycosylase and apyrimidinic (AP) lyase (endonuclease III) |
Echinococcus granulosus | EgrG_001090300 | endonuclease III protein 1 |
Entamoeba histolytica | EHI_083460 | endonuclease III, putative |
Echinococcus multilocularis | EmuJ_001090300 | endonuclease III protein 1 |
Giardia lamblia | GL50803_3595 | Endonuclease III |
Homo sapiens | ENSG00000065057 | nth endonuclease III-like 1 (E. coli) |
Leishmania braziliensis | LbrM.09.0070 | endonuclease III, putative |
Leishmania donovani | LdBPK_090070.1 | endonuclease III, putative |
Leishmania infantum | LinJ.09.0070 | endonuclease III, putative |
Leishmania major | LmjF.09.0050 | endonuclease III, putative |
Leishmania mexicana | LmxM.09.0050 | endonuclease III, putative |
Loa Loa (eye worm) | LOAG_15925 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03833 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10605 | hypothetical protein |
Mycobacterium leprae | ML2301c | PROBABLE ENDONUCLEASE III NTH (DNA-(APURINIC OR APYRIMIDINIC SITE)LYASE) (AP LYASE) (AP ENDONUCLEASE CLASS I) (ENDODEOXYRIBONUCL |
Mus musculus | ENSMUSG00000041429 | nth (endonuclease III)-like 1 (E.coli) |
Mycobacterium tuberculosis | Rv3674c | Probable endonuclease III Nth (DNA-(apurinic or apyrimidinic site)lyase) (AP lyase) (AP endonuclease class I) (endodeoxyribonucl |
Mycobacterium ulcerans | MUL_4248 | endonuclease III Nth |
Neospora caninum | NCLIV_070230 | hypothetical protein |
Oryza sativa | 9268162 | Os11g0267300 |
Onchocerca volvulus | OVOC3819 | Endonuclease III homolog |
Plasmodium berghei | PBANKA_1229500 | endonuclease III homologue, putative |
Plasmodium falciparum | PF3D7_0614800 | endonuclease III homologue, putative |
Plasmodium knowlesi | PKNH_1135200 | endonuclease III homologue, putative |
Plasmodium vivax | PVX_113875 | endonuclease III homologue, putative |
Plasmodium yoelii | PY05677 | Drosophila melanogaster CG9272 gene product |
Saccharomyces cerevisiae | YOL043C | bifunctional N-glycosylase/AP lyase NTG2 |
Saccharomyces cerevisiae | YAL015C | bifunctional N-glycosylase/AP lyase NTG1 |
Schistosoma japonicum | Sjp_0205880 | ko:K01741 DNA-(apurinic or apyrimidinic site) lyase [EC4.2.99.18], putative |
Schistosoma mansoni | Smp_006710 | endonuclease III |
Schmidtea mediterranea | mk4.044559.03 | Endonuclease III homolog |
Schmidtea mediterranea | mk4.052422.00 | Endonuclease III homolog |
Schmidtea mediterranea | mk4.007699.01 | Endonuclease III homolog |
Trypanosoma brucei gambiense | Tbg972.11.13530 | endonuclease III, putative |
Trypanosoma brucei | Tb927.11.12090 | endonuclease III, putative |
Trypanosoma congolense | TcIL3000.11.12720 | endonuclease III, putative |
Trypanosoma cruzi | TcCLB.504005.10 | endonuclease III, putative |
Trypanosoma cruzi | TcCLB.511481.50 | endonuclease III, putative |
Toxoplasma gondii | TGME49_305920 | endonuclease III family 1 protein |
Treponema pallidum | TP0775 | endonuclease III (nth) |
Theileria parva | TP03_0162 | endonuclease III, putative |
Trichomonas vaginalis | TVAG_113220 | endonuclease III, putative |
Trichomonas vaginalis | TVAG_447840 | endonuclease III, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0365 | EndoIII-related endonuclease |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.3910 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.3910 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.3910 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.3910 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1633 | Escherichia coli | non-essential | goodall |
TGME49_305920 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.